Trial Profile
Second of two phase I drug-interaction trials of flibanserin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Feb 2015
Price :
$35
*
At a glance
- Drugs Flibanserin (Primary)
- Indications Female sexual dysfunction
- Focus Adverse reactions; Registrational
- 17 Feb 2015 The NDA for flibanserin for hypoactive sexual desire disorder in premenopausal women has been resubmitted to the US FDA, according to a Sprout Pharmaceuticals media release.
- 14 Feb 2014 New trial record